PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1215
https://www.valueinhealthjournal.com/article/S1098-3015(12)02928-2/fulltext
Title :
PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02928-2&doi=10.1016/j.jval.2012.08.1215
First page :
A412
Section Title :
Cancer
Open access? :
No
Section Order :
715